logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
14/05/2025
The USD/JPY rose 0.5% intraday.
Latest
1 m ago
The World Gold Council stated in a report that global physical gold ETF inflows were around $11 billion in April, driven by rising gold prices and continued fund inflows. The total global gold ETF assets under management reached $379 billion at the end of April.
1 m ago
World Gold Council: Global gold ETF assets under management reached $379 billion at the end of April.
2 m ago
Citigroup: Downgrades AbbVie (ABBV.US) rating from Buy to Neutral, and the target price is adjusted from $210.00 to $205.00.
2 m ago
On May 14th, Novartis China announced that its breast cancer treatment product Kisqali (ribociclib succinate tablets) has been approved by the National Medical Products Administration for a new indication, to be used in combination with aromatase inhibitors as adjuvant therapy for early breast cancer patients with hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative and high risk of recurrence. (Jiemian News)
2 m ago
Novartis CDK4/6 inhibitor Kisqali approved for early breast cancer adjuvant therapy indication.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.